| Dr Joseph Sweeney, MD | |
|
593 Eddy St, Department Of Pathology Apc-12, Providence, RI 02903-4923 | |
| (401) 793-4810 | |
| (401) 351-5928 |
| Full Name | Dr Joseph Sweeney |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 48 Years |
| Location | 593 Eddy St, Providence, Rhode Island |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1871547398 | NPI | - | NPPES |
| JS03973 | Medicaid | RI |
| Facility Name | Location | Facility Type |
|---|---|---|
| The Miriam Hospital | Providence, RI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Miriam Hospital | 6901796408 | 186 |
| Rhode Island Hospital | 8921900044 | 303 |
News Archive
InterSystems Corporation, the global leader in software for connected healthcare, today announced that Rush University Medical Center has completed phase one of an organization-wide move to the InterSystems Ensemble® rapid integration and development platform.
Black patients are prescribed fewer pain medications than whites and few women receive medications strong enough to manage their chronic pain, according to a study in the August issue of Journal of Pain.University of Michigan Health System researchers studied nearly 200 patients with chronic pain who sought help from a specialty pain center. Researchers analyzed the number and potency of medicines they were already taking and the adequacy of pain management.
A new method for early and accurate breast cancer screening has been developed by researchers at Ben-Gurion University of the Negev and Soroka University Medical Center, using commercially available technology.
Today is an exciting day for men with advanced prostate cancer and the millions of families and loved ones who are profoundly affected. Today a new prostate cancer treatment option, Provenge, was approved by the Food and Drug Administration.
› Verified 8 days ago
| Entity Name | Rhode Island Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154537520 PECOS PAC ID: 8921900044 Enrollment ID: O20141017000105 |
News Archive
InterSystems Corporation, the global leader in software for connected healthcare, today announced that Rush University Medical Center has completed phase one of an organization-wide move to the InterSystems Ensemble® rapid integration and development platform.
Black patients are prescribed fewer pain medications than whites and few women receive medications strong enough to manage their chronic pain, according to a study in the August issue of Journal of Pain.University of Michigan Health System researchers studied nearly 200 patients with chronic pain who sought help from a specialty pain center. Researchers analyzed the number and potency of medicines they were already taking and the adequacy of pain management.
A new method for early and accurate breast cancer screening has been developed by researchers at Ben-Gurion University of the Negev and Soroka University Medical Center, using commercially available technology.
Today is an exciting day for men with advanced prostate cancer and the millions of families and loved ones who are profoundly affected. Today a new prostate cancer treatment option, Provenge, was approved by the Food and Drug Administration.
› Verified 8 days ago
| Entity Name | The Miriam Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598978744 PECOS PAC ID: 6901796408 Enrollment ID: O20170303000645 |
News Archive
InterSystems Corporation, the global leader in software for connected healthcare, today announced that Rush University Medical Center has completed phase one of an organization-wide move to the InterSystems Ensemble® rapid integration and development platform.
Black patients are prescribed fewer pain medications than whites and few women receive medications strong enough to manage their chronic pain, according to a study in the August issue of Journal of Pain.University of Michigan Health System researchers studied nearly 200 patients with chronic pain who sought help from a specialty pain center. Researchers analyzed the number and potency of medicines they were already taking and the adequacy of pain management.
A new method for early and accurate breast cancer screening has been developed by researchers at Ben-Gurion University of the Negev and Soroka University Medical Center, using commercially available technology.
Today is an exciting day for men with advanced prostate cancer and the millions of families and loved ones who are profoundly affected. Today a new prostate cancer treatment option, Provenge, was approved by the Food and Drug Administration.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joseph Sweeney, MD 593 Eddy St, Department Of Pathology Apc-12, Providence, RI 02903-4923 Ph: (401) 793-4810 | Dr Joseph Sweeney, MD 593 Eddy St, Department Of Pathology Apc-12, Providence, RI 02903-4923 Ph: (401) 793-4810 |
News Archive
InterSystems Corporation, the global leader in software for connected healthcare, today announced that Rush University Medical Center has completed phase one of an organization-wide move to the InterSystems Ensemble® rapid integration and development platform.
Black patients are prescribed fewer pain medications than whites and few women receive medications strong enough to manage their chronic pain, according to a study in the August issue of Journal of Pain.University of Michigan Health System researchers studied nearly 200 patients with chronic pain who sought help from a specialty pain center. Researchers analyzed the number and potency of medicines they were already taking and the adequacy of pain management.
A new method for early and accurate breast cancer screening has been developed by researchers at Ben-Gurion University of the Negev and Soroka University Medical Center, using commercially available technology.
Today is an exciting day for men with advanced prostate cancer and the millions of families and loved ones who are profoundly affected. Today a new prostate cancer treatment option, Provenge, was approved by the Food and Drug Administration.
› Verified 8 days ago
Dr. Ga Hie Nam, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 593 Eddy St, Providence, RI 02903 Phone: 401-444-5057 Fax: 401-444-8514 | |
N Peter Libbey, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 825 Chalkstone Ave, Roger Williams Medical Center/pathology Dept., Providence, RI 02908 Phone: 401-456-2162 Fax: 401-456-2131 | |
Sara Maleki, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 593 Eddy St, Apc 12, Providence, RI 02903 Phone: 401-444-8515 Fax: 401-444-8514 | |
Mirfrida Geller, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 593 Eddy St, Providence, RI 02903 Phone: 401-444-8450 Fax: 401-444-5088 | |
Dr. Lisa Goldstein, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 164 Summit Ave, Department Of Pathology, Providence, RI 02906 Phone: 401-793-4246 Fax: 401-274-5154 | |
Dr. Gladys Telang, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 593 Eddy St, Apc 10, Providence, RI 02903 Phone: 401-444-7959 Fax: 401-444-7144 | |
Xin He, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 593 Eddy St, Providence, RI 02903 Phone: 401-444-4923 |